Yuji Kashimoto

Statistics

Publications

Citations

130

H-Index

Active since

2008

Affiliations

Physicians Committee for Responsible Medicine(Current)

Yuji Kashimoto is an author at Physicians Committee for Responsible Medicine specializing in pharmacology, pharmacotherapy, and primary efficacy endpoints.

Publications per year

2008–2015

Publications

ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide exchange activity toward RhoA

Shuh‐hei Fujishiro, Susumu Tanimura, Shogo Mure et al. · Biochemical and Biophysical Research Communications · 2008 · 83 citations

Life Sciences, Cell Biology, Molecular Biology +7

A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan

Nagahide Takahashi, Tadaishi Koh, Yushin Tominaga et al. · The World Journal of Biological Psychiatry · 2014 · 25 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain

Tsutomu Arai, Yuji Kashimoto, Yoshifumi Ukyo et al. · Current Medical Research and Opinion · 2015 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–3 of 3